UD

Uma Devi Desireddy

Director Whole-Time Director DIN 07043582
DIN 07043582 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Uma Devi Desireddy

Data last updated:

Uma Devi Desireddy was a Whole-Time Director at Selmar Lab Private Limited (2015–2016) and Director at Ksm Drugs Private Limited (from 2015). The companies operate in Pharma.

DIN 07043582
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 13 Jan 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Selmar Lab Private Limited U24100TG2013PTC089489
Whole-Time Director16 Sep 20152013₹269 Cr (FY 2024)Active
Ksm Drugs Private Limited U24232TG2015PTC097252
Director13 Jan 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ksm Drugs Private Limited
Selmar Lab Private Limited
Premium access

Shareholding and investment profile for Uma Devi Desireddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Devi Desireddy

Uma Devi Desireddy was first appointed on 13 Jan 2015 as Director at Ksm Drugs Private Limited.

Uma Devi Desireddy held 2 earlier board appointments: Selmar Lab Private Limited (Whole-Time Director, 16 Sep 2015 to 12 Apr 2016); Ksm Drugs Private Limited (Director, from 13 Jan 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available